SPAC · Merger completed
Brookline Capital Acquisition Corp.
Business combination with Apexigen America, Inc.
Brookline Capital Acquisition Corp. is a blank-check company (SPAC) that raised $50M in its initial public offering on Jan 29, 2021. It completed its business combination with Apexigen America, Inc. on Jul 29, 2022; the combined company is Apexigen, Inc. (APGN). Ellenoff Grossman & Schole advised the SPAC and Graubard Miller advised the underwriters on the IPO.
- Status
- Merger completed
- IPO date
- Jan 29, 2021
- IPO size
- $50M
- Target
- Apexigen America, Inc. (Legacy Apexigen)
- Announced
- Mar 18, 2022
- Closed
- Jul 29, 2022
- Combined company
- Apexigen, Inc. (APGN)
- SPAC counsel (IPO)
- Ellenoff Grossman & Schole
- Underwriters' counsel (IPO)
- Graubard Miller
More on this SPAC for subscribers
- Trust balance and value per share
- Redemptions at each extension and at the merger vote
- Liquidation deadline and extension history
- PIPE and other committed financing
- Merger proxy, registration statement and investor presentation
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- IPO prospectus (424B4) Jan 29, 2021
- Deal announcement (8-K) Mar 18, 2022
- All filings on EDGAR CIK 1814140
Other deSPACs that closed in 2022
- D-Wave Quantum Inc.via DPCM Capital, Inc. · closed Aug 5, 2022
- ZeroFox Holdings, Inc.via L&F Acquisition Corp. · closed Aug 3, 2022
- New Semantixvia Alpha Capital Acquisition Co · closed Aug 3, 2022
- FiscalNote Holdings, Inc.via Duddell Street Acquisition Corp. · closed Jul 29, 2022
- Waldencast plcvia Waldencast Acquisition Corp. · closed Jul 27, 2022
- Getty Images Holdings, Inc.via CC Neuberger Principal Holdings II · closed Jul 22, 2022